Feng‐Wei Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 3
- Co-authors
- Dan Xie (16 shared papers)Jiewei Chen (12 shared papers)Rixin Chen (6 shared papers)Kai Han (8 shared papers)Xin‐Yuan Guan (3 shared papers)Jiaxing Zhang (2 shared papers)Feng Wang (2 shared papers)Zhizhong Pan (4 shared papers)
In The Last Decade
Feng‐Wei Wang
28 papers receiving 1.2k citations
Feng‐Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 639
- Molecular Biology 991
- Immunology 86
- Oncology 75
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Feng‐Wei Wang
This map shows the geographic impact of Feng‐Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Wei Wang more than expected).
Fields of papers citing papers by Feng‐Wei Wang
This network shows the impact of papers produced by Feng‐Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Wei Wang. The network helps show where Feng‐Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 548 |
| 2 | 2020 | 197 | |
| 3 | 2022 | 113 | |
| 4 | 2021 | 73 | |
| 5 | 2020 | 39 | |
| 6 | 2024 | 35 | |
| 7 | 2014 | 27 | |
| 8 | 2018 | 26 | |
| 9 | 2013 | 22 | |
| 10 | 2024 | 18 | |
| 11 | 2021 | 18 | |
| 12 | 2013 | 14 | |
| 13 | 2024 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2012 | 10 | |
| 18 | 2007 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2025 | 9 |
About Feng‐Wei Wang
Feng‐Wei Wang is a scholar working on Molecular Biology, Cancer Research, Materials Chemistry, Organic Chemistry and Biomedical Engineering, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (3 papers), Advanced Polymer Synthesis and Characterization (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), Pickering emulsions and particle stabilization (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (639 citations), Molecular Biology (991 citations), Immunology (86 citations), Oncology (75 citations) and Pulmonary and Respiratory Medicine (72 citations). Feng‐Wei Wang has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Dan Xie, Jiewei Chen, Rixin Chen, Kai Han, Xin‐Yuan Guan, Jiaxing Zhang, Feng Wang, Zhizhong Pan, Olivier Déas and Xiaodan Ma. Their work appears in journals such as Oncogene, Molecular Cancer, Signal Transduction and Targeted Therapy, Journal of Polymer Science Part A Polymer Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.